about
Diabetes DyslipidemiaAntioxidant properties of HDLEffect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.Gorlin syndrome.Effects of exenatide in poorly controlled type 2 diabetes.High-density lipoprotein cholesterol raising: does it matter?Lipoprotein (a): gene genie.The importance of considering LDL cholesterol response as well as cardiovascular risk in deciding who can benefit from statin therapy.A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report.Unintended positive and negative effects of drugs on lipoproteins.How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.Corneal confocal microscopy is a rapid reproducible ophthalmic technique for quantifying corneal nerve abnormalities.Don't miss familial hypercholesterolaemia in Achilles tendinopathy.Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and Diabetes.A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial.Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey.Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea.Hypercholesterolaemia - practical information for non-specialists.Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment.Circulating microRNAs -192 and -194 are associated with the presence and incidence of diabetes mellitusCardiovascular Risk in Type 1 Diabetes Mellitus.The impact of gestational hypercholesterolaemia on origins of diseaseDiabetic dyslipidaemiaCOVID-19: Impact of and on Diabetes
P50
Q26750905-26375C73-B61C-4151-9CD5-5EBE052D27A1Q26777244-7DF47208-5CF4-41E7-B4C4-69FFF5F3A19DQ36141729-8B25B298-0D0C-4060-A237-4C4320DAE114Q37292628-109C118B-E77A-417B-AA21-04E5930C7F0CQ37953113-1E84361D-A733-485E-97BF-AD0341B5D87AQ38111980-C346570E-6985-4B61-A305-4543D7F4C975Q38224560-9FF41358-B782-4092-8F8F-6AB99A39B1FCQ38224580-9C0C3247-DA32-4D2A-BF46-9CAF925BDB34Q38238702-64D6BC50-F5F9-45D3-B71B-8CCF1EB8F86EQ38535567-D07D1162-01DD-4883-BA53-DD5B235837D6Q38535570-2E277F06-B067-4798-ABAE-00FF3B16FB54Q38619914-A4EE3B94-7E11-4120-A5E3-009F945CF729Q45973805-DF21A78A-8C3E-42CE-90DF-EC6E450C633AQ47134287-22C98FA6-CC8C-4A82-A628-20DCD500C845Q47288033-575B518F-E043-450A-A490-E7355B859406Q47733906-596A777C-21FA-4CFA-BA19-F952A740179BQ48107171-E934359D-CC05-4823-AA1D-634EA5D452EAQ49592460-774B7FCB-2C50-4175-8A94-150CEA624AB1Q50336633-8664F804-338E-4507-BAC7-BE3345CAB9C4Q53592893-DD7C8A18-C784-48EE-8AF5-0CFA9A2F7979Q58700390-EDDD33E6-08DD-4C43-9F2A-077B203D5A1CQ64911301-63801108-285B-44D8-B356-636FE9B87196Q86599315-0658B845-7A7C-445F-8EDF-6EDC17ADA5C1Q89261937-B8F1675D-D2FF-49E1-8E06-0FB2327365D8Q96161994-AE1D5C32-406B-4D44-B0A5-081E9EF52AA0
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Jonathan D Schofield
@ast
Jonathan D Schofield
@en
Jonathan D Schofield
@es
Jonathan D Schofield
@nl
Jonathan D Schofield
@sl
type
label
Jonathan D Schofield
@ast
Jonathan D Schofield
@en
Jonathan D Schofield
@es
Jonathan D Schofield
@nl
Jonathan D Schofield
@sl
prefLabel
Jonathan D Schofield
@ast
Jonathan D Schofield
@en
Jonathan D Schofield
@es
Jonathan D Schofield
@nl
Jonathan D Schofield
@sl
P108
P106
P108
P21
P214
1930153834741364450005
P31
P496
0000-0001-6030-993X
P734
P735
P7859
viaf-1930153834741364450005